Researchers design drug-carrying nanoparticles that can be taken orally
Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far.
Now, researchers from MIT and Brigham and Women’s Hospital (BWH) have developed a new type of nanoparticle that can be delivered orally and absorbed through the digestive tract, allowing patients to simply take a pill instead of receiving injections.
In a paper appearing in the Nov. 27 online edition of Science Translational Medicine, the researchers used the particles to demonstrate oral delivery of insulin in mice, but they say the particles could be used to carry any kind of drug that can be encapsulated in a nanoparticle. The new nanoparticles are coated with antibodies that act as a key to unlock receptors found on the surfaces of cells that line the intestine, allowing the nanoparticles to break through the intestinal walls and enter the bloodstream.
This type of drug delivery could be especially useful in developing new treatments for conditions such as high cholesterol or arthritis. Patients with those diseases would be much more likely to take pills regularly than to make frequent visits to a doctor’s office to receive nanoparticle injections, say the researchers.
“If you were a patient and you had a choice, there’s just no question: Patients would always prefer drugs they can take orally,” says Robert Langer, the David H. Koch Institute Professor at MIT, a member of MIT’s Koch Institute for Integrative Cancer Research, and an author of the Science Translational Medicine paper.
Lead authors of the paper are former MIT grad student Eric Pridgen and former BWH postdoc Frank Alexis, and the senior author is Omid Farokhzad, director of the Laboratory of Nanomedicine and Biomaterials at BWH. Other authors are Timothy Kuo, a gastroenterologist at BWH; Etgar Levy-Nissenbaum, a former BWH postdoc; Rohit Karnik, an MIT associate professor of mechanical engineering; and Richard Blumberg, co-director of BWH’s Biomedical Research Institute.
No more injections
Several types of nanoparticles carrying chemotherapy drugs or short interfering RNA, which can turn off selected genes, are now in clinical trials to treat cancer and other diseases. These particles exploit the fact that tumors and other diseased tissues are surrounded by leaky blood vessels. After the particles are intravenously injected into patients, they seep through those leaky vessels and release their payload at the tumor site.
For nanoparticles to be taken orally, they need to be able to get through the intestinal lining, which is made of a layer of epithelial cells that join together to form impenetrable barriers called tight junctions.
“The key challenge is how to make a nanoparticle get through this barrier of cells. Whenever cells want to form a barrier, they make these attachments from cell to cell, analogous to a brick wall where the bricks are the cells and the mortar is the attachments, and nothing can penetrate that wall,” Farokhzad says.
Researchers have previously tried to break through this wall by temporarily disrupting the tight junctions, allowing drugs through. However, this approach can have unwanted side effects because when the barriers are broken, harmful bacteria can also get through.
To build nanoparticles that can selectively break through the barrier, the researchers took advantage of previous work that revealed how babies absorb antibodies from their mothers’ milk, boosting their own immune defenses. Those antibodies grab onto a cell surface receptor called the FcRN, granting them access through the cells of the intestinal lining into adjacent blood vessels.
The researchers coated their nanoparticles with Fc proteins — the part of the antibody that binds to the FcRN receptor, which is also found in adult intestinal cells. The nanoparticles, made of a biocompatible polymer called PLA-PEG, can carry a large drug payload, such as insulin, in their core.
After the particles are ingested, the Fc proteins grab on to the FcRN in the intestinal lining and gain entry, bringing the entire nanoparticle along with them.
“It illustrates a very general concept where we can use these receptors to traffic nanoparticles that could contain pretty much anything. Any molecule that has difficulty crossing the barrier could be loaded in the nanoparticle and trafficked across,” Karnik says.
The researchers’ discovery of how this type of particle can penetrate cells is a key step to achieving oral nanoparticle delivery, says Edith Mathiowitz, a professor of molecular pharmacology, physiology, and biotechnology at Brown University.
The Latest Google Headlines on:
Nanoparticle drug delivery
[google_news title=”” keyword=”nanoparticle drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Nanoparticle drug delivery
- Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platformon September 29, 2023 at 12:57 pm
Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.
- Ocular Drug Delivery Technology Market Surging At A 8.4% CAGR To Cross US$ 39 Billion By 2032 X Heraldon September 28, 2023 at 7:48 pm
The ocular drug delivery technology market is anticipated to grow from US$ 16.4 billion in FY 2021 to US$ 17.74 billion in FY 2022. The industry saw ...
- Do liposomes make food supplements more effective? An expert explains common myths about these productson September 28, 2023 at 9:45 am
There has been an explosion in nutritional supplements that promise a superior product because they contain nanoparticles called liposomes. But there's a lot of misleading information and outright ...
- Nanoparticle Drug Delivery Systems Market 2023 Size Share and Growth 2023-2030on September 25, 2023 at 4:36 am
The Global Nanoparticle Drug Delivery Systems Market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2031. In 2021, the market is growing at a steady ...
- Defence's Accum(R)-mRNA Lipid Nanoparticles Elicit Antibody Response 2X Stronger than Standard mRNA Vaccineson September 25, 2023 at 12:15 am
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug ...
- Nanoparticles made from plant viruses could be farmers' new ally in pest controlon September 21, 2023 at 10:19 am
The work is detailed in a paper published in Nano Letters. Steinmetz's team drew inspiration from nanomedicine, where nanoparticles are being created for targeted drug delivery, and adapted this ...
- Liposomal and Lipid Nanoparticle Drug Delivery Systems Market: (2023-2031) | Trends and Growth Prospectson September 20, 2023 at 11:55 pm
Based on our latest research findings from [2023], the global Liposomal and Lipid Nanoparticle Drug Delivery Systems market is expected to achieve a value of USD 11949.45 million by 2031 ...
- New nanoparticle-based treatment could solve acne problems for millionson September 20, 2023 at 1:04 am
A study led by researchers from the University of South Australia, the University of Adelaide, and the Aix-Marseille Universite in France, may have discovered a potential game-changer for acne ...
- Acne Treatment May Be Improved With Nanoparticle Deliveryon September 19, 2023 at 2:27 am
Acne makes life miserable for around 800 million teenagers and adults worldwide. In a new study, researchers have shown how a new antibacterial compound encased in tiny, soft nanoparticles is ...
- Nanoparticle gene delivery system shows promise for treating ARDSon September 18, 2023 at 11:54 pm
Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute ...
The Latest Google Headlines on:
Oral nanoparticle delivery
[google_news title=”” keyword=”oral nanoparticle delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Oral nanoparticle delivery
- New Theory Explains How Nanoparticles Enter and Exit the Tumorson September 26, 2023 at 7:19 am
We are excited to have a better understanding of the nanoparticle tumor delivery process. The results of these fundamental studies on nanoparticle entry and exit will be important for engineering ...
- Researchers challenge long-standing theory guiding nanoparticle treatment of tumorson September 25, 2023 at 2:47 pm
Researchers at the University of Toronto have developed a new theory to explain how nanoparticles enter and exit the tumors they are meant to treat, potentially rewriting an understanding of cancer ...
- Liposomal and Lipid Nanoparticle Drug Delivery Systems Market: (2023-2031) | Trends and Growth Prospectson September 20, 2023 at 11:55 pm
Based on our latest research findings from [2023], the global Liposomal and Lipid Nanoparticle Drug Delivery Systems market is expected to achieve a value of USD 11949.45 million by 2031 ...
- New nanoparticle-based treatment could solve acne problems for millionson September 20, 2023 at 1:04 am
A study led by researchers from the University of South Australia, the University of Adelaide, and the Aix-Marseille Universite in France, may have discovered a potential game-changer for acne ...
- Acne Treatment May Be Improved With Nanoparticle Deliveryon September 19, 2023 at 2:27 am
Acne makes life miserable for around 800 million teenagers and adults worldwide. In a new study, researchers have shown how a new antibacterial compound encased in tiny, soft nanoparticles is ...
- Nanoparticle Drug Delivery Systems Market (New Report) Size, Trends Across Globally | 2023-2030on September 14, 2023 at 1:31 pm
"Nanoparticle Drug Delivery Systems Market" Size, Share, Growth Report 2023-2030 | | No. of pages: 123 Report which offers an in-depth analysis Grounded on Applications (Neurology, Oncology ...
- Nanoparticle Based Delivery of Gene Editing Enzymeson September 13, 2023 at 2:59 am
I will describe a non-viral Cas9 delivery vehicle, termed CRISPR-Gold, which can induce homology directed DNA repair (HDR) in vivo by directly delivering Cas9 protein, gRNA, and donor DNA. CRISPR-Gold ...
- 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summiton March 30, 2023 at 8:46 am
2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought ...
- Using Nanoparticles in Targeted Drug Delivery and Photothermal Therapyon November 18, 2022 at 8:29 am
Discover the latest research and advances in nanoparticle technology. Nanoparticles are growing in popularity for drug delivery and photothermal therapy. A given nanoparticle can bear a specific ...
- Next Generation Lipid-Based Nanoparticles Delivery Summit | July 19-21, 2022on April 28, 2022 at 5:45 am
The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...